GAD1 and Hyperglycemia: Our results showed that immunization with CTB-Ins-GAD fusion protein resulted in remission from hyperglycemia in 60% of mice, which is more often than the CTB-GAD fusion protein or WT-treated mice within 40 days of initial hyperglycemia (p<0.05) (Fig 3).